Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ XCL1/XCL2 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA599826
Description
Antibody detects endogenous levels of total XCL1/2.
Lymphotactin, otherwise known as XCL1, is a member of the C-chemokine family that uniquely acts as a chemoattractant for lymphocytes, but not monocytes or neutrophils, suggesting an important regulatory role in lymphocyte trafficking and inflammation. Lymphotactin, shown to signal through chemokine XC receptor 1 (XCR1), is detected at the highest level in the spleen and at low levels in the lungs, small intestine and colon, and is abundantly and selectively expressed by activated T cells, in particular CD8+ T cells, and is also produced by NK cells.
Specifications
XCL1/XCL2 | |
Polyclonal | |
Unconjugated | |
XCL1 | |
AI661682; ATAC; C motif chemokine 1; c motif chemokine 2; chemokine (C motif) ligand 1; chemokine (C motif) ligand 2; cytokine SCM-1; Cytokine SCM-1 beta; Lptn; LTN; Lymphotactin; lymphotaxin; SCM1; SCM-1; SCM1A; SCM-1a; SCM-1-alpha; SCM1B; SCM-1b; Scyc1; SCYC2; single cysteine motif 1a; small inducible cytokine subfamily C, member 1 (lymphotactin); small inducible cytokine subfamily C, member 2; small-inducible cytokine C1; XC chemokine ligand 1; XC chemokine ligand 2; X-C motif chemokine ligand 1; X-C motif chemokine ligand 2; Xcl1; XCL2 | |
Rabbit | |
Affinity chromatography | |
RUO | |
16963, 6375, 6846 | |
-20°C | |
Liquid |
Western Blot | |
1 mg/mL | |
PBS with 50% glycerol and 0.02% sodium azide; pH 7.4 | |
P47992, P47993, Q9UBD3 | |
XCL1, XCL2 | |
A synthesized peptide derived from human XCL2(Accession Q9UBD3), corresponding to amino acid residues F60-V110. | |
100 μL | |
Primary | |
Human, Mouse | |
Antibody | |
IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction